Inovio Pharmaceuticals INO
NASDAQ INO
$0.90 +0.06 (+7.14%)
At close: Oct 23, 2026 · 4:00 PM EDT

Inovio Pharmaceuticals (INO) Cash & Current Investments (2010 - 2026)

Updated

Inovio Pharmaceuticals' Cash & Current Investments was $36.67 million in Q2 2026, down 22.9% from $47.55 million a year earlier and down 2.7% from the prior quarter.

Analysis

Inovio Pharmaceuticals (INO) Cash & Current Investments (2010 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Inovio Pharmaceuticals came in at $58.51 million, down 37.8% from FY2024.

  • Cash & Current Investments has now declined for five consecutive years, with a five-year compound annual growth rate of -32.3% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $94.11 million in FY2024 (-35.2%), $145.29 million in FY2023 (-42.6%), $253 million in FY2022 (-37.0%) and $401.31 million in FY2021 (-2.5%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q2 2013.
  • Compared with a year earlier, Cash & Current Investments has declined for 19 straight quarters, with an average decline of 40.3% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q3 2021 (growth of 17.1%); the worst was Q2 2025 (a decline of 56.9%).
  • Per Business Quant data, INO's Cash & Current Investments in the three quarters before Q2 2026 was $37.68 million (Q1 2026), $58.51 million (Q4 2025) and $50.8 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Inovio Pharmaceuticals 73.46 Mn -110.21 Mn - 36.67 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 36.67 Mn
Mar 31, 2026 37.68 Mn
Dec 31, 2025 58.51 Mn
Sep 30, 2025 50.80 Mn
Jun 30, 2025 47.55 Mn
Mar 31, 2025 68.36 Mn
Dec 31, 2024 94.11 Mn
Sep 30, 2024 84.80 Mn
Jun 30, 2024 110.42 Mn
Mar 31, 2024 105.61 Mn
Dec 31, 2023 145.29 Mn
Sep 30, 2023 167.47 Mn
Jun 30, 2023 194.93 Mn
Mar 31, 2023 223.75 Mn
Dec 31, 2022 253.00 Mn
Sep 30, 2022 281.88 Mn
Jun 30, 2022 348.13 Mn
Mar 31, 2022 360.39 Mn
Dec 31, 2021 401.31 Mn
Sep 30, 2021 394.94 Mn
API Access

Inovio Pharmaceuticals Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=INO&period=max&api_key=YOUR_API_KEY